This inventor holds 4 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Beecham Group Plc, Pfizer Corporation. Active years: 1991-2002.
Location History:
- Dorking, GB (1996)
- Betchworth, GB (1991 - 2002)
Company Filing History:
2 out of 2,198 
1 out of 855 
1 out of 4,486 
Years Active: 1991-2002
Title: The Innovations of Peter Robin Shelley
Introduction
Peter Robin Shelley is a notable inventor based in Betchworth, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antifungal agents and immunosuppressants. With a total of 4 patents to his name, Shelley's work has had a considerable impact on medical science.
Latest Patents
Among his latest patents are innovative compounds such as 3-desmethylrapamycin or derivatives thereof, which are processes for their preparation and their use as antifungal agents and immunosuppressants. Additionally, he has developed anthelmintic milbemycins and avermectins, which include novel compounds useful in the treatment of helminthiasis in humans and animals. These compounds are characterized by complex chemical structures that demonstrate his expertise in medicinal chemistry.
Career Highlights
Throughout his career, Peter Robin Shelley has worked with prominent companies in the pharmaceutical industry, including SmithKline Beecham Corporation and Beecham Group Plc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in the field.
Collaborations
Peter has collaborated with esteemed colleagues such as Roderick J Dorgan and Rhona Mary Banks. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective projects.
Conclusion
Peter Robin Shelley is a distinguished inventor whose work has significantly advanced the field of pharmaceuticals. His patents and collaborations reflect his commitment to improving health outcomes through innovative solutions.